Sanne A Hoogenboom
Overview
Explore the profile of Sanne A Hoogenboom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vladut C, Steiner C, Lohr M, Gokce D, Maisonneuve P, Hank T, et al.
Pancreatology
. 2024 Dec;
25(1):98-107.
PMID: 39706752
Objective: In the last decade there has been increasing interest in defining pancreatic steatosis (PS) and establishing its association with pancreatic ductal adenocarcinoma (PDAC). However, no consensus guidelines have yet...
2.
Engels M, Berger C, Mahoney D, Hoogenboom S, Sarwal D, Klatte D, et al.
Clin Gastroenterol Hepatol
. 2024 Oct;
PMID: 39477082
Background And Aims: In previous studies, methylated DNA markers (MDMs) have been identified in pancreatic juice (PJ) for detecting pancreatic ductal adenocarcinoma (PDAC). In this prospective multicenter study, the sensitivity...
3.
Hoogenboom S, Engels M, Chuprin A, van Hooft J, LeGout J, Wallace M, et al.
Abdom Radiol (NY)
. 2022 Sep;
47(12):4160-4172.
PMID: 36127473
Purpose: To characterize the prevalence of missed pancreatic masses and pancreatic ductal adenocarcinoma (PDAC)-related findings on CT and MRI between pre-diagnostic patients and healthy individuals. Materials And Methods: Patients diagnosed...
4.
Umans D, Hoogenboom S, Sissingh N, Lekkerkerker S, Verdonk R, van Hooft J
World J Gastroenterol
. 2021 Jun;
27(23):3148-3157.
PMID: 34163103
Acute pancreatitis (AP), chronic pancreatitis (CP) and pancreatic cancer are three distinct pancreatic diseases with different prognoses and treatment options. However, it may be difficult to differentiate between benign and...
5.
Bansal R, Hoogenboom S, Garg A, Brahmbhatt B
Pancreas
. 2021 Feb;
50(2):e16-e17.
PMID: 33565805
No abstract available.
6.
Hoogenboom S, Bolan C, Chuprin A, Raimondo M, van Hooft J, Wallace M, et al.
Pancreatology
. 2021 Jan;
21(2):428-433.
PMID: 33485792
Background: The prevalence of pancreatic ductal adenocarcinoma (PDAC) is on the rise, driven by factors such as aging and an increasing prevalence of obesity and diabetes mellitus. To improve the...
7.
Gorris M, Hoogenboom S, Wallace M, van Hooft J
Dig Endosc
. 2020 Oct;
33(2):231-241.
PMID: 33065754
Novel artificial intelligence techniques are emerging in all fields of healthcare, including gastroenterology. The aim of this review is to give an overview of artificial intelligence applications in the management...
8.
Corral J, Hoogenboom S, Kroner P, Vazquez-Roque M, Picco M, Farraye F, et al.
Gastrointest Endosc
. 2020 May;
92(3):524-534.e6.
PMID: 32360302
Background And Aims: The novel coronavirus disease 2019 (COVID-19) pandemic has limited endoscopy utilization, causing significant health and economic losses. We aim to model the impact of polymerase chain reaction...
9.
Ghoz H, Kesler A, Hoogenboom S, Gavi F, Brahmbhatt B, Cangemi J, et al.
J Gastrointest Surg
. 2019 Dec;
24(2):270-277.
PMID: 31797257
Background: Ulcerative colitis (UC) is primarily medically managed. Colectomy is required in patients with refractory disease or severe complications. Older studies have reported 20-year colectomy rates of over 50%, but...
10.
Lekkerkerker S, Hoogenboom S, de Koning F, Schoorlemmer A, Busch O, Boermeester M, et al.
Pancreas
. 2019 Apr;
48(4):e26-e27.
PMID: 30973468
No abstract available.